Examkin

Question

Difficulty: HardMedical Literature and Drug Advertisement Interpretation

A hospital therapeutics committee is reviewing several drug advertisements and recent clinical trial publications to update the institutional formulary. They must critically appraise the methodology and promotional claims to avoid adopting flawed or misleading evidence. Match each study excerpt or promotional claim with the specific methodological flaw, bias, or interpretative error it most clearly demonstrates.

  • Patients prescribed a new targeted therapy for refractory inflammatory bowel disease had significantly higher baseline steroid use than those maintained on standard therapy, heavily skewing the observational data.Confounding by indication
  • An advertisement for a novel anti-migraine medication emphasizes a highly favorable efficacy finding in males under 4040, a calculation performed only after the trial's primary endpoint for the general cohort failed.Post-hoc data dredging
  • A phase 33 trial evaluating a new lipid-lowering agent reported a statistically significant reduction in LDL cholesterol (p=0.04p = 0.04), but the absolute mean difference between the intervention and standard care was only 1.5 mg/dL1.5 \text{ mg/dL}.Lack of clinical significance
  • During a trial for a new disease-modifying osteoarthritis drug, 35%35\% of the treatment group withdrew due to gastrointestinal adverse effects. The published efficacy analysis only included patients who completed the entire protocol.Attrition bias

Answer

The correct matches align the observational baseline imbalances with confounding by indication, the failed-trial subgroup analysis with post-hoc data dredging, the 1.5 mg/dL LDL drop with lack of clinical significance, and the protocol-completers-only analysis with attrition bias.
Each excerpt describes a classic methodological flaw tested on the USMLE Step 3. Confounding by indication occurs when the indication for the drug (severity of illness) affects the outcome, often seen in observational data. Post-hoc data dredging involves analyzing subgroups after the fact to artificially find 'positive' results. Clinical significance requires the magnitude of the effect to be meaningful for patient care, regardless of statistical significance (p-value). Attrition bias occurs when participant dropout is non-random and those lost to follow-up are improperly excluded from the final analysis.

Step-by-Step Solution

1
Evaluate the first excerpt describing baseline imbalances in an observational study.
Matches with 'Confounding by indication'.
Because treatment was not randomized, sicker patients (higher baseline steroid use) were preferentially prescribed the new drug, confusing the disease severity with the treatment effect.
2
Evaluate the second excerpt regarding the anti-migraine advertisement.
Matches with 'Post-hoc data dredging'.
Searching for positive subgroups only after the primary outcome fails is a classic example of p-hacking or data dredging.
3
Evaluate the third excerpt regarding the lipid-lowering trial.
Matches with 'Lack of clinical significance'.
A 1.5 mg/dL reduction in LDL, despite a p-value of 0.04, is mathematically significant but not clinically meaningful for cardiovascular risk reduction.
4
Evaluate the fourth excerpt regarding dropouts in the osteoarthritis trial.
Matches with 'Attrition bias'.
Using a per-protocol (completer) analysis when there is differential dropout due to adverse effects heavily biases the results in favor of the drug, failing to utilize the intention-to-treat principle.

Key Concept

Medical Literature and Drug Advertisement Interpretation
Estimated Time:1m 30s
Rate this question

Topics

Medical Literature and Drug Advertisement Interpretation

More questions from this topic